Banque Pictet & Cie SA Sells 6,604 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Banque Pictet & Cie SA trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 43,823 shares of the medical equipment provider’s stock after selling 6,604 shares during the quarter. Banque Pictet & Cie SA’s holdings in Intuitive Surgical were worth $22,874,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth about $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical in the 3rd quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $591.39 on Friday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $210.64 billion, a price-to-earnings ratio of 92.26, a PEG ratio of 5.67 and a beta of 1.39. The firm has a 50 day moving average price of $557.70 and a 200-day moving average price of $517.49.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on ISRG shares. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.